Cytena

Cytena is a private German company providing specialized instrumentation for single-cell manipulation, a critical step in biopharmaceutical development and advanced therapies. Its core technology allows for the gentle, precise, and efficient isolation of single cells, which accelerates the creation of stable cell lines for biologic drug production and supports research in cell therapy. By addressing key bottlenecks in bioprocessing, Cytena positions itself as an enabler for the broader biotech and pharmaceutical industry. The company likely generates revenue through the sale of its instruments and associated consumables to academic, biotech, and pharmaceutical clients.

Proprietary microfluidic-based single-cell dispensing and analysis systems for gentle, image-documented isolation of individual cells.

Competes in the single-cell isolation and analysis segment against companies like Bruker (Berkeley Lights), Molecular Devices, Namocell, and Miltenyi Biotec. Differentiation is based on gentle microfluidic dispensing, integrated imaging for clonality proof, and a focus on bioprocessing workflow integration rather than pure analysis.